Home - Products - Others - Other Targets - N-p-coumaroyl-N'-caffeoylputrescine

N-p-coumaroyl-N'-caffeoylputrescine

CAS No. 1138156-77-0

N-p-coumaroyl-N'-caffeoylputrescine( —— )

Catalog No. M30849 CAS No. 1138156-77-0

N-p-Coumaroyl-N'-caffeoylputrescine is a natural product of Exochorda, Rosaceae. N-p-Coumaroyl-N'-caffeoylputrescine can be used as a reference standard.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1029 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    N-p-coumaroyl-N'-caffeoylputrescine
  • Note
    Research use only, not for human use.
  • Brief Description
    N-p-Coumaroyl-N'-caffeoylputrescine is a natural product of Exochorda, Rosaceae. N-p-Coumaroyl-N'-caffeoylputrescine can be used as a reference standard.
  • Description
    N-p-Coumaroyl-N'-caffeoylputrescine is a natural product of Exochorda, Rosaceae. N-p-Coumaroyl-N'-caffeoylputrescine can be used as a reference standard.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1138156-77-0
  • Formula Weight
    396.4
  • Molecular Formula
    C22H24N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CP-316819

    CP-316819 (GPi 819) is a potent inhibitor of glycogen phosphorylase (GPase) with hypoglycemic effects, inhibits huSMGPa and huLGPa, maintains neuronal activity during hypoglycemia, and can be used in the study of hyperglycemia.

  • m-PEG9-SH

    m-PEG9-SH is a PEG-based PROTAC linker that can be used in the synthesis of PROTAC.

  • Calmodulin Binding P...

    Calmodulin Binding Peptide 1 is a high affinity (pM) CaM-binding peptide derived from smooth muscle myosin light-chain kinase (MLCK peptide), which strongly inhibits IP3-induced Ca2+ release .